PTC Therapeutics | PTCT - Операционный доход





Операционный доход Изменить Дата
Acadia Pharmaceuticals USD 71.72M 33.88M 2026-09
Alnylam Pharmaceuticals USD 179.66M 67.06M 2026-09
Amgen USD 4.68B 65M 2026-09
BioCryst Pharmaceuticals USD 98.46M 161.92M 2026-06
Biogen USD 419.5M 663.3M 2026-09
BioMarin Pharmaceutical USD 205.6M 100M 2026-09
Cytokinetics USD -167.09M 12.08M 2026-09
Daiichi Sankyo JPY 108.7B 23.6B 2026-09
Enanta Pharmaceuticals USD -23.54M 98.15M 2024-12
Gilead Sciences USD 3.85B 1.17B 2026-06
Incyte USD -707.47M 1.41B 2026-09
Ionis Pharmaceuticals USD -102.29M 15.71M 2026-06
Ironwood Pharmaceuticals USD 33.22M 7.58M 2024-12
Karyopharm Therapeutics USD -26.76M 8.92M 2026-03
Novartis USD 5.14B 392M 2026-09
Pfizer USD 662M 5M 2026-09
PTC Therapeutics USD 148.98M 103.09M 2026-06
Puma Biotechnology USD 22.08M 24.26M 2024-09
Roche Holding CHF 11.46B 1.91B 2026-06
Sangamo BioSciences USD -33.51M 12.77M 2024-06
Sarepta Therapeutics USD 13.29M 345.14M 2026-06
TG Therapeutics USD 21.67M 13.12M 2026-06
Ultragenyx Pharmaceutical USD -110M 35M 2026-09
Vertex Pharmaceuticals USD 1.26B 11.3M 2026-09
Xencor USD -36.6M 41.26M 2026-06